In vivo effects of interleukin-1 alpha on regenerating mouse bone marrow myeloid colony-forming cells after treatment with 5-fluorouracil

Leukemia. 1989 Dec;3(12):893-6.

Abstract

Injection of a single dose of recombinant human interleukin-1 alpha (r-hu-IL-1 alpha) into mice 24 hr after 5-fluorouracil (FU) treatment resulted in an increased rate of recovery of three types of colony-forming cells (CFCs) in the bone marrow. Myeloid progenitors with high proliferative potential (responsive to CSF-1 + IL-3 + IL-1 alpha), low proliferative potential (responsive to CSF-1), megakaryocyte progenitors, and total nucleated cells per femur increased up to 5-fold, 7-fold, 3-fold, and 3-fold, respectively, in a dose related fashion compared with the control FU treated marrows. The kinetics of FU kill and recovery of these CFCs are shown.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Marrow / drug effects*
  • Colony-Stimulating Factors / pharmacology
  • Dose-Response Relationship, Drug
  • Fluorouracil / pharmacology*
  • Hematopoietic Stem Cells / drug effects*
  • Interleukin-1 / pharmacology*
  • Interleukin-3 / pharmacology
  • Macrophage Colony-Stimulating Factor
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Recombinant Proteins / pharmacology
  • Regeneration

Substances

  • Colony-Stimulating Factors
  • Interleukin-1
  • Interleukin-3
  • Recombinant Proteins
  • Macrophage Colony-Stimulating Factor
  • Fluorouracil